{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:04:27Z","timestamp":1789452267510,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1124\/jpet.109.164830","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T21:12:26Z","timestamp":1265058746000},"page":"540-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Evidence for De Novo Synthesis of Lysophosphatidic Acid in the Spinal Cord through Phospholipase A2 and Autotaxin in Nerve Injury-Induced Neuropathic Pain"],"prefix":"10.1016","volume":"333","author":[{"given":"Lin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.164830_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1074\/jbc.270.1.445","article-title":"Inhibition of macrophage Ca-independent phospholipase A by bromoenol lactone and trifluoromethyl ketones.","volume":"270","author":"Ackermann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.semcdb.2004.05.001","article-title":"Mechanisms of lysophosphatidic acid production.","volume":"15","author":"Aoki","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1124\/jpet.109.164830_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2008.06.005","article-title":"Two pathways for lysophosphatidic acid production.","volume":"1781","author":"Aoki","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.109.164830_bib4","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.1074\/jbc.M206812200","article-title":"Serum lysophosphatidic acid is produced through diverse phospholipase pathways.","volume":"277","author":"Aoki","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib5","doi-asserted-by":"crossref","first-page":"R466","DOI":"10.1152\/ajpregu.2001.280.2.R466","article-title":"Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo.","volume":"280","author":"Balazs","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.109.164830_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets.","volume":"291","author":"Eichholtz","year":"1993","journal-title":"Biochem J"},{"key":"10.1124\/jpet.109.164830_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/dbio.2000.9930","article-title":"Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology.","volume":"228","author":"Fukushima","year":"2000","journal-title":"Dev Biol"},{"key":"10.1124\/jpet.109.164830_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(02)02976-9","article-title":"Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.","volume":"523","author":"Hama","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.109.164830_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1124\/jpet.109.164830_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique.","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.109.164830_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8069-4-6","article-title":"Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.","volume":"4","author":"Inoue","year":"2008","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.109.164830_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1471-4159.2008.05725.x","article-title":"Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.","volume":"107","author":"Inoue","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.109.164830_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/jpet.109.164830_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0026-895X(24)12460-1","article-title":"Functional comparisons of the lysophosphatidic acid receptors, LP(A1)\/VZG-1\/EDG-2, LP(A2)\/EDG-4, and LP(A3)\/EDG-7 in neuronal cell lines using a retrovirus expression system.","volume":"58","author":"Ishii","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.164830_bib15","doi-asserted-by":"crossref","first-page":"32807","DOI":"10.1074\/jbc.M202568200","article-title":"Identification of calcium-independent phospholipase A2 (iPLA2) \u03b2, and not iPLA2\u03b3, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells.","volume":"277","author":"Jenkins","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.bjp.0706116","article-title":"Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2.","volume":"144","author":"Karin Killermann","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.109.164830_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(03)00165-7","article-title":"A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method.","volume":"333","author":"Kishimoto","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1124\/jpet.109.164830_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1471-4159.2009.05987.x","article-title":"Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist.","volume":"109","author":"Ma","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.109.164830_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-5-64","article-title":"Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.","volume":"5","author":"Ma","year":"2009","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.109.164830_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer.","volume":"3","author":"Mills","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.109.164830_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.20798","article-title":"A novel role of phospholipase A2 in mediating spinal cord secondary injury.","volume":"59","author":"Nai-Kui","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.109.164830_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.84","article-title":"G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth.","volume":"40","author":"Pasternack","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.109.164830_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1124\/jpet.102.046250","article-title":"Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain.","volume":"304","author":"Rashid","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.164830_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-4159.2004.02933.x","article-title":"Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.","volume":"92","author":"Sato","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.109.164830_bib25","doi-asserted-by":"crossref","first-page":"11909","DOI":"10.1074\/jbc.M210878200","article-title":"Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry.","volume":"278","author":"Smani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib26","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1021\/bi00074a003","article-title":"Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.","volume":"32","author":"Street","year":"1993","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.109.164830_bib27","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1194\/jlr.M200242-JLR200","article-title":"Lysophosphatidic acid, a growth factor-like lipid, in the saliva.","volume":"43","author":"Sugiura","year":"2002","journal-title":"J. Lipid Res"},{"key":"10.1124\/jpet.109.164830_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.","volume":"14","author":"Tager","year":"2008","journal-title":"Nat Med"},{"key":"10.1124\/jpet.109.164830_bib29","doi-asserted-by":"crossref","first-page":"25822","DOI":"10.1074\/jbc.M605142200","article-title":"Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.","volume":"281","author":"Tanaka","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib30","doi-asserted-by":"crossref","first-page":"H2048","DOI":"10.1152\/ajpheart.1995.268.5.H2048","article-title":"Lysophosphatidic acid alters cerebrovascular reactivity in piglets.","volume":"268","author":"Tigyi","year":"1995","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.109.164830_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1095\/biolreprod61.1.195","article-title":"Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients.","volume":"61","author":"Tokumura","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1124\/jpet.109.164830_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2005.06.003","article-title":"Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms.","volume":"109","author":"Ueda","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.109.164830_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-4-11","article-title":"Peripheral mechanisms of neuropathic pain- involvement of lysophosphatidic acid receptor-mediated demyelination.","volume":"4","author":"Ueda","year":"2008","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.109.164830_bib34","doi-asserted-by":"crossref","first-page":"21155","DOI":"10.1074\/jbc.M413183200","article-title":"Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.","volume":"280","author":"van Meeteren","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.164830_bib35","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1523\/JNEUROSCI.21-18-07069.2001","article-title":"Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling.","volume":"21","author":"Weiner","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.109.164830_bib36","first-page":"1223","article-title":"Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.","volume":"1","author":"Xu","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.109.164830_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature03505","article-title":"LPA3-mediated lysophosphatidic acid signaling in embryo implantation and spacing.","volume":"435","author":"Ye","year":"2005","journal-title":"Nature"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524457996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524457996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.164830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:29:34Z","timestamp":1775309374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524457996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0022356524457996"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.164830","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for De Novo Synthesis of Lysophosphatidic Acid in the Spinal Cord through Phospholipase A2 and Autotaxin in Nerve Injury-Induced Neuropathic Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.164830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}